Abstract. Melanoma presents a serious threat to human health but the underlying mechanisms have not been fully identified. Increasing evidence indicates that microRNAs exert a significant influence on the tumorigenesis and metastasis of different types of cancer. The present study aimed to identify the role of microRNA (miR)-367 in the initiation and progression of melanoma and investigate its potential target. A total of 50 melanoma samples and 25 benign nevi tissues were used in the present study. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were performed to determine the expression of mRNA and protein, respectively. Cell proliferation and invasion were assessed by CCK-8, wound healing and Transwell assays. A proposed target mRNA of miR-367 was determined using a luciferase reporter assay and an in vivo xenograft model was used to evaluate the function of miR-367 in the progression of melanoma. It was revealed that miR-367 was overexpressed in melanoma tissues and cell lines. The miR-367 level in tumor tissues was positively correlated with tumor thickness, tumor stage, lymph node involvement, distant metastasis and the patient survival rate. A high miR-367 level was observed to enhance the growth, migration and invasion of melanoma cells. Conversely, low miR-367 levels suppressed the proliferation and invasion of melanoma cells. Furthermore, miR-367 was revealed to bind directly to phosphatase and tensin homolog (PTEN) mRNA and regulate the expression of the PTEN protein. miR-367 markedly increased the growth and invasion of melanoma cells, whereas the cotransfection of PTEN vectors limited the promoting function of miR-367 in the proliferation and invasion of A375 cells. The upregulation of miR-367 promoted tumor growth in vivo. In conclusion, the results revealed that miR-367 serves a positive role in the development of melanoma and may be an important target for the treatment of cutaneous melanoma.
Introduction
Cutaneous melanoma, developing in melanocytes that produce melanin, is a most pernicious tumors in skin malignancy and have a poor prognosis for survival (1) . Emerging evidences indicate that melanoma gives rise to the majority of skin tumor-associated death (2-4), incontrollable growth and metastasis early are the main characteristics in the progression of cutaneous melanoma (5) . The etiology of cutaneous melanoma is multifactorial and complicated including environmental and genetic factors (6, 7) . Therefore, it is extremely crucial that further investigation of gene expression and regulation in the development of melanoma. miRNAs are small and noncoding RNA molecules which play key roles in post-transcriptional regulation of gene expression by binding to the 3'-UTR of targeted mRNA (8) (9) (10) . Previous studies manifested microRNAs were involved in a range of biological activities including cell proliferation, transformation, and tumorigenesis (11) . Emerging evidences identified that abnormal miRNAs expression was associated with the initiation and procession of tumors (12) (13) (14) .
PTEN, known as phosphatase and tensin homolog deleted on chromosome 10, is a phosphoinositide phosphatase that plays a tumor suppressor role in malignant melanoma (15) . Increasing evidences revealed that microRNAs were involved in the tumorigenesis of tumors by regulating the expression of PTEN. For example, miR-500a promoted the invasion and migration of hepatocarcinoma via suppressing the expression of PTEN (16) . miR-20b enhanced prostate cancer growth through targeting PTEN (17) . So far, the regulatory relationship remains obscure and needs to be elucidated carefully between microRNAs and PTEN in malignant cutaneous melanoma. miR-367 had been reported to be involved in the tumorigenesis and transformation of different cancers (18, 19) , and it played tumor promotor or tumor suppressor roles in diverse tumors. For instance, overexpression of miR-367 was associated with a unfavorable prognosis and enhanced non-small cell lung cancer growth by binding to FBXW7 (20) . In miR-367 enhances the proliferation and invasion of cutaneous malignant melanoma by regulating phosphatase and tensin homolog expression contrast, miR-367 was found to be related with TNM stage of patients and suppress gastric cancer development via targeting Rab23 (21) . Up to date, the effect of miR-367 on cutaneous melanoma remains unclear. The present report aims to detect the expression of miR-367 in cutaneous melanoma tissues and cell lines, and investigate the regulatory mechanism of miR-367 on the development of cutaneous melanoma. Cell migration assay. Wound healing assay was used to study cell migration. Melanoma cells were seeded and incubated in 6-well plates until monolayers were developed. A plastic scriber was used to make an artificial wound, and the image of the wound was served as baseline. Cells were then washed twice with PBS and incubated in DMEM with 10% fetal bovine serum at 37˚C for 48 h. Cell migration capacity was assessed by subtracting the final wound width from the initial wound width.
Materials and methods

Patients
Transwell invasion assay. Transwell invasion assay was performed to evaluate cell invasion ability. A Transwell chamber was precoated with Matrigel (BD Biosciences, Franklin Lakes, NJ, USA). Cells (2x10 5 ) were seeded into the upper chamber and incubated in serum free medium. The incubating media with 20% fetal bovine serum were added into the lower chamber to attract cells. After being cultured for 48 h, cells on the upper chamber were cleared with a swab. Cells after migration were fixed and stained with 0.5% crystal violet, photographed and counted under a microscope.
Luciferase reporter analysis. The 3'-UTR region of PTEN or the mutated sequence was cloned into pMIR-REPORT vectors. miR-367 mimics, or corresponding control was transfected Table I . Association between clinical findings and the miR-367 level in individuals with cutaneous melanoma. 
Results
Overexpression of miR-367 was confirmed in cutaneous melanoma and was correlated with poor prognosis in patients with cutaneous melanoma. qRT-PCR was used to determine the expression of miR-367 in 50 of cutaneous melanoma tissues and 25 of benign nevi tissue. Our results identified that the miR-367 level was significantly elevated in melanoma tissues in comparison with benign nevi tissues (Fig. 1A) . High expression of miR-367 was confirmed in A375 cells, WM35 cells, SK-MEL-2 cells and SK-MEL-5 cells compared with HEMa-LP cells, and the highest level of miR-367 was found in A375 cells line (Fig. 1B ). The miR-367 level was negatively correlated with the PTEN level in melanoma tissues (Fig. 1C) .
Patients with melanoma were separated into high miR-367 expression group (n=25) and low miR-367 expression (n=25) according to the relative median value of miR-367 (median, 2.665; Min-Max, 1.030-3.680). The correlation was analyzed between the miR-367 expression and clinical characteristics of patients with melanoma. The correlation was not statistically significant between the miR-367 level and age, sex of patients with melanoma, but high expression of miR-367 was significantly correlated with tumor thickness, TNM stage, lymph node involvement and distant metastasis of malignant melanoma as shown in Table I . Besides, high miR-367 level was positively correlated with decreased overall survival (Fig. 1D) . The results manifested that miR-367 played a promoting role in the development of melanoma.
High level of miR-367 enhanced the growth and invasion of A375 cells. A375 cells were selected for further experiments
due to the highest level of miR-367 in A375 cells. The miR-367 level was significantly upregulated in miR-367 mimics group in comparison with miR-control group ( Fig. 2A) . CCK-8 assay, Transwell assays and wound healing assay confirmed that upregulation of miR-367 distinctly promoted the proliferation, invasion and migration of A375 cells ( Fig. 2A) . Conversely, the miR-367 level was decreased in A375 cells after transfection with miR-367 inhibitor (Fig. 2B) . The transfection of miR-367 inhibitor attenuated the proliferation, invasion and migration of A375 cells (Fig. 2B ). These data identified that miR-367 play a critical role in the growth, invasion and migration of A375 cells.
PTEN mRNA was identified as the functional downstream target of miR-367.
Bioinformatics analysis (TargetScan 7.0 and miRanda) was performed to investigate the downstream targets of miR-367 in melanoma cells. Retrieval results manifested that 3'-UTR of PTEN contained a direct binding sequence of miR-367 (Fig. 3) , miR-367 interaction with binding sequence of 3'-UTR-PTEN was confirmed by luciferase reporter assay. The results indicated that miR-367 distinctly inhibited luciferase activity of PTEN in wild-type, however, had no effect on that of PTEN in mutated type (Fig. 3B) . Western blot analysis was implemented to identify whether miR-367 could regulate PTEN expression in A375 cells or not. The results further identified that high level of miR-367 remarkably suppressed PTEN expression in A375 cells. Furthermore, the phosphorylation of AKT was increased by the transfection of miR-367 mimics into A375 cells (Fig. 4A) . On the other hand, the PTEN expression was significantly elevated and the phosphorylation of AKT was downregulated in A375 cells after transfection with miR-367 inhibitors (Fig. 4B) . Collectively, the results identified that PTEN was an important downstream targeting mRNA of miR-367 in A375 cells. group (Fig. 4C) . The transfection of miR-367 mimics remarkably suppressed the expression of PTEN and enhanced the phosphorylation of AKT in A375 cells, but the cotransfection of miR-367 mimics with PTEN vectors attenuated the effect of miR-367 mimics on the expression of PTEN and the phosphorylation of AKT in A375 cells. In addition, upregulation of miR-367 enhanced the growth, invasion and migration of A375 cells, however, PTEN vectors ameliorated the ability of growth, invasion, and migration of A375 cells transfected with miR-367 mimics. Finally, PTEN vectors and miR-367 mimics had no significant effect on AKT level in A375 cells (Fig. 5) . Briefly, miR-367 was able to promote the proliferation, invasion and migration of A375 cells via targeting PTEN.
Upregulation of PTEN attenuated the effect of miR-367 on
The effect of miR-367 on melanoma growth in a xenograft tumor model. A xenograft tumor model was applied to confirm the promoting function of miR-367 in the progression of melanoma. The xenograft tumors were collected for determination of weight and volume. The result showed that the volume of tumor in miR-367 mimics group was significantly increased in comparison with miR-control group at 10, 15, 20 and 25 days after A375 cells injection (Fig. 3D) , and the weight of tumor in miR-367 mimics group was markedly larger than that in miR-control group at 25 days after A375 cells injection (Fig. 3C) . Therefore, it was identified strongly that forced expression of miR-367 markedly augmented the growth of xenograft tumors. In addition, the PTEN expression in tissues was significantly decreased, but the miR-367 level in tissues was distinctly increased in miR-367 mimics group compared with miR-control group (Fig. 3E-G) . Accordingly, enhancing function of miR-367 in the malignant melanoma growth was confirmed in vivo.
Discussion
miRNA has been identified as a critical transcriptional mediator in many biological activities including the development of tumorgenesis by binding to 3'-UTR of its targeting mRNA. The aberrant expression of miR-367 was found definitely in many types of tumors (22, 23) . The association between miR-367 and cutaneous malignant melanoma has not been clearly elucidated up to date. Accordingly, we investigated the expression and underlying regulatory function of miR-367 in malignant melanoma. As a result, we found that miR-367 was distinctly overexpressed in cutaneous melanoma tissues and cell lines, and negatively correlated with the PTEN level in cutaneous melanoma tissues. High expression of miR-367 was markedly related with the malignant clinical characteristics of individuals with melanoma. Next, overexpression of miR-367 enhanced A375 cells proliferation and Transwell migration, and inhibited PTEN expression, upregulation of PTEN alleviated partially the enhancing effect of miR-367 on the growth, invasion and migration of A375 cells. Finally, nude mice models study identified in vivo that overexpression of miR-367 promoted xenograft tumor development. All of these results combined manifested that miR-367 promoted melanoma progression by, at least in part, regulating the PTEN expression. PTEN is a crucial tumor inhibitor gene that is involved in the occurence and progression of many types of malignant tumor (24) including malignant melanoma (25) . The protein derived from the gene can reduce phosphatidylinositol-3,4,5-trisphosphate level and exert a tumor inhibitor role through PTEN/AKT pathway (26) . In this study, PTEN was identified to be an important functional target of miR-367 in melanoma cells. Firstly, the binding target of miR-367 was discovered in 3'UTR-PTEN mRNA. Secondly, miR-367 decreased distinctly the luciferase activity in the wild PTEN, however, did not affect luciferase activity in the mutated PTEN. Thirdly, forced expression of miR-367 inhibited expression of PTEN and promoted the phosphorylation of AKT, whereas downregulation of miR-367 distinctly promoted the expression of PTEN and alleviated the phosphorylation of AKT. Upregulation of PTEN suppressed the pro-tumor function of miR-367 in A375 cells. Finally, The PTEN expression was distinctly reduced but the miR-367 level was markedly raised in xenograft tumors in miR-367 mimics group in comparison with miR-control group. All results combined identified that miR-367 played a pro-tumor role in A375 cells via regulating PTEN expression. PTEN was a potential mediator of the PTEN/PI3K/AKT pathway (27) . These results further confirmed miR-367 could regulate the phosphorylation of AKT level by targeting PTEN mRNA, and be involved in malignant behaviors of A375 cells via regulating PTEN/AKT pathway.
Together, this study confirms the miR-367 level is distinctly upregulated in cutaneous melanoma. Overexpression of miR-367 is correlated with malignant clinical characteristics of individuals with cutaneous melanoma. miR-367 augments the proliferation and invasion of melanoma. Furthermore, miR-367 plays promoting roles on the development of melanoma via modulating PTEN expression. Regulation of miR-367 expression may be a novel and crucial strategy for cutaneous melanoma treatment.
